Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, IASLC's membership base includes more than 10,000 lung and thoracic cancer specialists across all disciplines in over 100 countries. The association's core purpose is to conquer lung and other thoracic cancers on a worldwide basis by promoting research, education, and collaboration among scientists, clinicians, and patients. IASLC publishes the Journal of Thoracic Oncology (JTO) and organizes the renowned World Conference on Lung Cancer (WCLC) among other educational events.
The headquarters serves as the central administrative and operational hub for IASLC's global activities, including membership services, organization of major conferences like the WCLC, development of educational programs, management of publications, and coordination of advocacy and research initiatives.
The headquarters likely comprises modern office facilities designed to support a global non-profit's administrative and collaborative needs, including meeting spaces and technological infrastructure for international communication.
As a mission-driven non-profit, the work culture at IASLC headquarters is characterized by professionalism, collaboration, and a strong dedication to the fight against lung cancer. Staff are typically passionate about contributing to global health outcomes and advancing oncological science.
IASLC's headquarters is pivotal as the coordinating center for an extensive international network of researchers, clinicians, patient advocates, and industry partners focused on thoracic oncology. It facilitates global collaboration, knowledge dissemination, and the strategic direction of the association's worldwide efforts.
IASLC maintains a significant global presence through its diverse membership spanning over 100 countries. Its worldwide functions are primarily supported through international conferences (such as the World Conference on Lung Cancer held in various global locations), regional meetings, educational workshops, online resources, publications like the Journal of Thoracic Oncology, and collaborative research initiatives. While the administrative headquarters is in Colorado, USA, IASLC's activities, educational outreach, and member engagement are inherently global, fostering a worldwide community dedicated to tackling thoracic cancers.
9000 E. Nichols Ave, Suite 215
Centennial
Colorado
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, International Association for the Study of Lung Cancer' leadership includes:
International Association for the Study of Lung Cancer has been backed by several prominent investors over the years, including:
IASLC experienced a key leadership change in the last 12 months with the appointment of Destiny M. H. Coleman as the new Chief Executive Officer in May 2024, succeeding Dave Mesko. This transition is pivotal for the ongoing strategic leadership and operational excellence of the association.
Discover the tools International Association for the Study of Lung Cancer uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
The International Association for the Study of Lung Cancer (IASLC) commonly uses an email format consisting of the first initial followed by the last name for its staff members (e.g., jsmith@iaslc.org). General inquiries can often be directed to departmental email addresses like info@iaslc.org or membership@iaslc.org.
[first_initial][last]@iaslc.org
Format
dcoleman@iaslc.org
Example
80%
Success rate
IASLC Website / PR Newswire • May 1, 2024
The International Association for the Study of Lung Cancer (IASLC) announced the appointment of Destiny M. H. Coleman as its new Chief Executive Officer. Coleman assumed the role on May 1, 2024, succeeding Dave Mesko, JD....more
IASLC Website • March 12, 2024
IASLC revealed the lineup of distinguished keynote speakers for its upcoming 2024 World Conference on Lung Cancer (WCLC 2024), set to take place in San Diego, California. The speakers will address pivotal topics in lung cancer research, treatment, and patient advocacy....more
Business Wire • January 10, 2024
The IASLC unveiled the comprehensive program for its 2024 Targeted Therapies of Lung Cancer Meeting (TTLC24), held in February in Santa Monica, California. The program featured leading experts discussing the latest advancements and future directions in precision medicine for lung cancer....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including International Association for the Study of Lung Cancer, are just a search away.